Collagens | Glycosaminoglycans | Proteoglycans and glycoproteins | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
I | II | III | VI | KS | DS, C4S | C4S | C6S | Agg | Link | Versican | Tenascin | |
The figures indicate the number of specimens (maximum six) in which positive labelling was seen. There was no distinction between the labelling patterns of the calcified and uncalcified zones of fibrocartilage with any antibody, but only the outer (and not the inner) part of the zone of uncalcified fibrocartilage labelled for type I collagen, versican, and tenascin in the lateral epicondylar entheses*. | ||||||||||||
Agg, aggrecan; C4S, chondroitin-4-sulphate; C6S, chondroitin-6-sulphate; DS, dermatan sulphate; KS, keratan sulphate; Link, link protein. | ||||||||||||
Lateral epicondyle | ||||||||||||
Tendon attachment | ||||||||||||
Bone matrix | 6 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Fibrocartilage | 6* | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6* | 6* |
Fibrous zone | 6 | 3 | 6 | 6 | 6 | 6 | 6 | 4 | 3 | 3 | 6 | 4 |
Ligament attachment | ||||||||||||
Bone matrix | 6 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Fibrocartilage | 6* | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6* | 6* |
Fibrous zone | 6 | 3 | 6 | 6 | 6 | 6 | 6 | 4 | 3 | 3 | 6 | 4 |
Medial epicondyle | ||||||||||||
Tendon attachment | ||||||||||||
Bone matrix | 6 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Fibrocartilage | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Fibrous zone | 6 | 3 | 6 | 6 | 6 | 6 | 6 | 3 | 2 | 3 | 6 | 4 |
Ligament attachment | ||||||||||||
Bone matrix | 6 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Fibrocartilage | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Fibrous zone | 6 | 3 | 6 | 6 | 6 | 6 | 6 | 1 | 2 | 3 | 6 | 4 |